Research Library — Page 62 | Reta Compare

3563 research articles. Page 62 of 143.

Articles

• Exploring the Broader Health Benefits of Retatrutide Beyond Glycemic Control
• Retatrutide Demonstrates Significant Weight Loss in Obese Patients
• Eli Lilly Advances Retatrutide in Phase III Trials for Obesity Management
• Retatrutide Demonstrates Significant Weight Loss Compared to Placebo in Recent Study
• Retatrutide Shows Promising Results in Recent Weight Loss Trials
• Exploring Retatrutide: A New Approach to Weight Loss Without Exercise
• Retatrutide Shows Promising Weight Loss Results in Phase 2 Clinical Trial
• Retatrutide's Potential Role in Resolving Non-Alcoholic Fatty Liver Disease
• Retatrutide Shows Promising Results in Weight Loss and Cardiometabolic Health
• Significant Weight Loss Observed in Retatrutide Obesity Drug Study
• Retatrutide Shows Promising Weight Loss Results in Experimental Trials
• Retatrutide Shows Promising Weight Loss Potential Compared to Ozempic
• Retatrutide Shows Potential for Significant Weight Loss in Phase 2 Trial
• Mid-Stage Study Highlights Efficacy of Retatrutide for Weight Loss
• Retatrutide Shows Significant Weight Reduction in Obesity and Type 2 Diabetes
• Retatrutide Shows Promising Weight Reduction in Phase 2 Clinical Trial
• Retatrutide Shows Promising Weight Loss Results in Phase 2 Study
• Retatrutide Demonstrates Superior Weight Loss Compared to Established GLP-1 Agonists
• Retatrutide: Insights from a Phase 1b Trial of a Novel Triple Receptor Agonist
• Exploring 5-Amino-1MQ: A Promising NNMT Inhibitor for Disease Management
• Exploring 5-Amino-1MQ: Insights from Nicotinamide N-methyltransferase Research
• Exploring 5-Amino-1MQ: A Potential Therapeutic for Chronic Kidney Disease
• Exploring the Role of 5-Amino-1MQ in Ovarian Cancer and Xist Regulation
• Exploring 5-Amino-1MQ: Enhancements in Limb Function for Peripheral Artery Disease
• Exploring 5-Amino-1MQ: A Promising NNMT Inhibitor in Cancer Research